Incannex Healthcare Inc. Current Financial Assets At Amortised Cost
Incannex Healthcare Inc. (IXHL) had Current Financial Assets At Amortised Cost of $28.90 million as of 2022-12-31, per its 6-K filed 2023-02-27.
Discontinued › Notes
ifrs-full:CurrentFinancialAssetsAtAmortisedCost · last filed 2023-02-27
- 2022-12-31: Current Financial Assets At Amortised Cost $28.90M.
| Period end | Current Financial Assets At Amortised Cost |
|---|---|
| 2022-12-31 | $28.90M 6-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |